File photo
File photo

Community Blood Center declares blood shortage, requests donors

December 12, 2016 04:38 PM

UPDATED December 12, 2016 05:50 PM

More Videos

  • First treatment that genetically modifies patients’ cells to destroy cancer approved by FDA

    T-cells are one of immune system’s key soldiers, targeting infected or abnormal cells but cancer can block those defenses. Now scientists are genetically modifying patients own cells to make them smarter and tougher at seeking out and destroying cancer. One version is called CAR-T cell therapy, T-cells customized to zero in on a patients specific kind of cancer.